Holen Sie sich die Stockscreener-App
4.35
2.11%
0.09
Handel nachbörslich:
4.29
-0.06
-1.38%
Schlusskurs vom Vortag:
$4.26
Offen:
$4.3
24-Stunden-Volumen:
1.98M
Relative Volume:
0.67
Marktkapitalisierung:
$737.04M
Einnahmen:
$101.21M
Nettoeinkommen (Verlust:
$-569.00K
KGV:
-217.50
EPS:
-0.02
Netto-Cashflow:
$-56.88M
1W Leistung:
+2.35%
1M Leistung:
+11.83%
6M Leistung:
+74.70%
1J Leistung:
+342.61%
1-Tages-Spanne:
$4.24
$4.43
1-Wochen-Bereich:
$3.981
$4.50
52-Wochen-Spanne:
$0.40
$4.66
Cytomx Therapeutics Inc Stock (CTMX) Company Profile
Firmenname
Cytomx Therapeutics Inc
Sektor
Branche
Telefon
650.515.3185
Adresse
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie CTMX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTMX
Cytomx Therapeutics Inc
|
4.35 | 721.79M | 101.21M | -569.00K | -56.88M | -0.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-17 | Fortgesetzt | Barclays | Overweight |
| 2025-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2025-05-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-04-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-05-28 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-05-09 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-05-06 | Hochstufung | Jefferies | Hold → Buy |
| 2024-04-22 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-11-14 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-07-07 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-07-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-07-07 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-06-24 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-01-18 | Hochstufung | Barclays | Underweight → Overweight |
| 2021-11-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-28 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-03-29 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-23 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-22 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-06-01 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-24 | Hochstufung | Wedbush | Neutral → Outperform |
| 2020-03-04 | Eingeleitet | Barclays | Equal Weight |
| 2019-11-20 | Eingeleitet | Guggenheim | Buy |
| 2019-11-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-06-13 | Eingeleitet | Mizuho | Buy |
| 2019-05-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-03-11 | Eingeleitet | Barclays | Overweight |
| 2018-11-26 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-10-15 | Eingeleitet | Goldman | Neutral |
| 2018-09-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-06-01 | Eingeleitet | SunTrust | Buy |
| 2018-01-05 | Eingeleitet | Citigroup | Buy |
| 2017-09-08 | Eingeleitet | Wedbush | Outperform |
| 2017-03-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2017-01-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2015-11-02 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Cytomx Therapeutics Inc Aktie (CTMX) Neueste Nachrichten
Is CytomX Therapeutics Inc. stock gaining market shareJuly 2025 Action & Weekly Setup with ROI Potential - ulpravda.ru
Gainers Report: Will CytomX Therapeutics Inc stock recover faster than marketWeekly Volume Report & Free Technical Pattern Based Buy Signals - moha.gov.vn
Is CytomX Therapeutics Inc. stock dividend yield sustainableJuly 2025 Decliners & Real-Time Volume Analysis Alerts - ulpravda.ru
Is CytomX Therapeutics Inc. stock a top pick in earnings seasonJuly 2025 Summary & Weekly Top Gainers Alerts - ulpravda.ru
Fed Meeting: Why CytomX Therapeutics Inc. stock could outperform in 2025Portfolio Profit Report & Intraday High Probability Alerts - ulpravda.ru
Why CytomX Therapeutics Inc. stock could outperform in 2025Weekly Earnings Recap & Momentum Based Trading Signals - ulpravda.ru
Is CytomX Therapeutics Inc. stock a safe investment in uncertain marketsWeekly Trading Summary & AI Powered Market Entry Strategies - ulpravda.ru
CytomX Therapeutics announces business update and company milestones for 2026 - MarketScreener
Cytomx Therapeutics Announces Business Update And Company Milestones For 2026 - TradingView — Track All Markets
CytomX Therapeutics (CTMX) Reveals Plans for 2026 with Promising Clinical Developments - GuruFocus
CytomX Therapeutics Announces Business Update and Company Milestones for 2026 - MarketScreener
Piper Sandler and HC Wainwright stay bullish on CytomX (CTMX) - MSN
Why CytomX Therapeutics Inc. stock is recommended by analystsMarket Depth Overview & Low Entry Investment Growth - ulpravda.ru
Piper Sandler and H.C. Wainwright Stay Bullish on CytomX (CTMX) - Finviz
Is CytomX Therapeutics Inc a good long term investmentVolume Analysis Techniques & Free Trading Signals to Sharpen Your Edge - earlytimes.in
What drives CytomX Therapeutics Inc 6C1 stock priceEmerging Market Stocks & High Return Stock Picks - earlytimes.in
What analysts say about CytomX Therapeutics Inc 6C1 stockEquity Performance Review & Collaborate and Win Together - earlytimes.in
CytomX Therapeutics (NASDAQ:CTMX) Hits New 1-Year HighHere's Why - MarketBeat
What drives CytomX Therapeutics Inc stock priceWeekly Market Snapshot & Investor Community Interactions - earlytimes.in
Chart Watch: Is CytomX Therapeutics Inc stock a safe investment in uncertain markets2025 Bull vs Bear & Verified Short-Term Trading Plans - moha.gov.vn
Will CytomX Therapeutics Inc. stock recover faster than peersChart Pattern Recognition & Exceptional Return Stocks - bollywoodhelpline.com
237,081 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Precision Wealth Strategies LLC - MarketBeat
Inspire Investing LLC Acquires Shares of 522,482 CytomX Therapeutics, Inc. $CTMX - MarketBeat
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
CytomX Therapeutics (STU:6C1) EV-to-OCF : -7.46 (As of Dec. 26, 2025) - GuruFocus
CytomX Therapeutics (NASDAQ:CTMX) Trading Up 5.4%Here's Why - MarketBeat
CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) (NASDAQ:CTMX) - Seeking Alpha
CTMX (CytomX Therapeutics) EV-to-OCF : -7.47 (As of Dec. 22, 2025) - GuruFocus
CytomX Therapeutics, Inc.(NasdaqGS:CTMX) added to S&P Biotechnology Select Industry Index - marketscreener.com
Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress - Insider Monkey
Can CytomX Therapeutics Inc. stock sustain free cash flow growthJuly 2025 News Drivers & Weekly High Return Opportunities - ulpravda.ru
Market Outlook: Why CytomX Therapeutics Inc stock could outperform in 2025Buy Signal & Free High Accuracy Swing Entry Alerts - moha.gov.vn
Sell Signal: Will CytomX Therapeutics Inc stock recover faster than peersJuly 2025 Summary & High Return Trade Guides - moha.gov.vn
How CytomX Therapeutics Inc. stock trades during market volatilityJuly 2025 Update & Fast Gain Swing Trade Alerts - Улправда
Is CytomX Therapeutics Inc. (6C1) stock undervalued by metricsJuly 2025 Sentiment & Community Trade Idea Sharing Platform - Улправда
CytomX Therapeutics' (NASDAQ:CTMX) earnings growth rate lags the 256% return delivered to shareholders - simplywall.st
Pullback Watch: What market sentiment indicators show for CytomX Therapeutics Inc. (6C1) stockMarket Performance Recap & Long-Term Safe Investment Plans - Улправда
Will CytomX Therapeutics Inc. stock split attract more investorsBuy Signal & Expert-Curated Trade Recommendations - Улправда
CytomX Therapeutics (NASDAQ:CTMX) Trading Down 3.5%What's Next? - MarketBeat
Market Overview: Will CytomX Therapeutics Inc. stock split attract more investorsTake Profit & Fast Momentum Stock Entry Tips - Улправда
Analyst sentiment remains bullish on CytomX Therapeutics (CTMX) amid CX-2051 therapy progress - MSN
CytomX: Easiest Money May Have Been Made, Although Pipeline Remains Compelling - Seeking Alpha
Can CytomX Therapeutics Stock Hold Up When Markets Turn? - Trefis
CytomX Therapeutics2025 Funding Rounds & List of Investors - Tracxn
5,769,230 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Vivo Capital LLC - MarketBeat
Can CytomX Therapeutics Stock Recover If Markets Fall? - Trefis
What analysts say about CytomX Therapeutics Inc stockVolume Weighted Average Price & Explosive Profit Potential - earlytimes.in
With CytomX Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
What Analysts Think Is Changing the CytomX Therapeutics Story After Recent Cancer Developments - Yahoo Finance
CytomX Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of key data By Investing.com - Investing.com South Africa
CytomX Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of key data - Investing.com UK
Finanzdaten der Cytomx Therapeutics Inc-Aktie (CTMX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):